The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse

被引：1
|
作者：
Canbay, A
Feldstein, A
Baskin-Bey, E
Bronk, SF
Gerken, G
Gores, GJ
机构：
[1] Mayo Clin & Mayo Fdn, Mayo Med Sch, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA
[2] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany
来源：
JOURNAL OF HEPATOLOGY | 2004年 / 40卷
关键词：
D O I：
10.1016/S0168-8278(04)90022-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
22
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse
    Canbay, A
    Feldstein, A
    Baskin-Bey, E
    Bronk, SF
    Gores, GJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03): : 1191 - 1196
  • [2] The pan-caspase inhibitor, IDN-6556, attenuates human liver preservation injury
    Baskin-Bey, Edwina S.
    Washburn, Kenneth
    Feng, Sandy
    Oltersdorf, Tilman
    Shapiro, David
    Burgart, Lawrence
    Garrity-Park, Megan
    van Vilsteren, Frederike G. I.
    Oliver, Lawrence K.
    Rosen, Charles B.
    Gores, Gregory
    HEPATOLOGY, 2006, 44 (04) : 190A - 190A
  • [3] A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo rat model of warm and cold ischemia
    Hoglen, Niel C.
    Anselmo, Dean M.
    Katori, Masamichi
    Kaldas, Marian
    Shen, Xiu-Da
    Valentino, Karen L.
    Lassman, Charles
    Busuttil, Ronald W.
    Kupiec-Weglinski, Jerzy W.
    Farmer, Douglas G.
    LIVER TRANSPLANTATION, 2007, 13 (03) : 361 - 366
  • [4] Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury
    Baskin-Bey, E. S.
    Washburn, K.
    Feng, S.
    Oltersdorf, T.
    Shapiro, D.
    Huyghe, MiRa
    Burgart, L.
    Garrity-Park, M.
    van Vilsteren, F. G. I.
    Oliver, L. K.
    Rosen, C. B.
    Gores, G. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (01) : 218 - 225
  • [5] The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury
    Natori, S
    Higuchi, H
    Contreras, P
    Gores, GJ
    LIVER TRANSPLANTATION, 2003, 9 (03) : 278 - 284
  • [6] The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
    Barreyro, Fernando J.
    Holod, Silvia
    Finocchietto, Paola V.
    Camino, Alejandra M.
    Aquino, Jorge B.
    Avagnina, Alejandra
    Carreras, Maria C.
    Poderoso, Juan J.
    Gores, Gregory J.
    LIVER INTERNATIONAL, 2015, 35 (03) : 953 - 966
  • [7] Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse
    Anan, Akira
    Baskin-Bey, Edwina S.
    Isomoto, Hajime
    Mott, Justin L.
    Bronk, Steven F.
    Albrecht, Jeffrey H.
    Gores, Gregory J.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (04): : G709 - G716
  • [8] Oral IDN-6556, an anti-apoptotic caspase inhibitor, lowers aminotransferases in HCV patients
    Schiff, ER
    Pockros, P
    Shiffman, ML
    McHutchison, J
    Gish, R
    Afdhal, NH
    Makhviladze, M
    Huyghe, M
    Hecht, D
    Oltersdorf, T
    Shapiro, DA
    GASTROENTEROLOGY, 2004, 126 (04) : A668 - A668
  • [9] IDN-6556, the first anti-apoptotic caspase inhibitor: Preclinical efficacy and safety.
    Hoglen, NC
    Fisher, CD
    Hirakawa, BP
    Valentino, KL
    Shapiro, DA
    Contreras, PC
    HEPATOLOGY, 2003, 38 (04) : 579A - 579A
  • [10] First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes
    Valentino, KL
    Gutierrez, M
    Sanchez, R
    Winship, MJ
    Shapiro, DA
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2003, 41 (10) : 441 - 449
12345